Sort   by:  
 Page size 
UnknownLong-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial.
Not available
S-EPMC12426824 | biostudies-literature
UnknownThe DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT).
Not available
S-EPMC7544566 | biostudies-literature
UnknownThe importance of considering competing risks in recurrence analysis of intracranial meningioma.
Not available
S-EPMC10876814 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownCombining genome-wide polygenic scores with registry data for colorectal cancer risk-based screening.
Not available
S-EPMC13642245 | biostudies-literature
UnknownInduced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trial.
Not available
S-EPMC10928558 | biostudies-literature
UnknownAssociations of Mitochondrial and Nuclear Mitochondrial Variants and Genes with Seven Metabolic Traits.
Not available
S-EPMC6323610 | biostudies-literature
UnknownLong-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
Sort   by:  
 Page size